Large gap with delayed quotes
|
Last quote
11/04/2025
-
17:09:27
|
Bid
11/04/2025 -
17:12:03
|
Bid Volume |
Ask
11/04/2025 -
17:12:03
|
Ask Volume |
|---|---|---|---|---|
|
142.59
+0.63
(
+0.44% )
|
142.32
|
100 |
142.91
|
100 |
Analysis date: 31.10.2025
Global Evaluation
Slightly positive
Slightly positive
The stock is classified in the slightly positive zone since 31.10.2025.
Interest
Weak
Weak
Two stars since 03.10.2025.
Earnings Rev Trend
Negative
Negative
Compared to seven weeks ago, the analysts have lowered their earnings per share estimates. This negative trend began 03.10.2025 at a price of 137.03.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 15.08.2025.
4wk Rel Perf
-0.25%
-0.25%
The four-week dividend-adjusted performance versus SP500 is .
Sensibility
Low
Low
The stock has been on the low-sensitivity level since 29.08.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.44%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.43%.
Mkt Cap in $bn
14.28
14.28
With a market capitalization >$8bn, NEUROCRINE BIOSCIENCES is considered a large-cap stock.
G/PE Ratio
1.58
1.58
A "Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings" ratio higher than 1.5 indicates that the stock's price presents a discount to growth >40% in this case.
LT P/E
11.89
11.89
The estimated PE is for the year 2029.
LT Growth
18.73%
18.73%
The annualized growth estimate is for the current year to 2029.
Avg. Nb analysts
17
17
Over the last seven weeks, an average of 17 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
80
80
For 1% of index variation, the stock varies on average by 0.80%.
Correlation
0.41
0.41
40.88% of stock movements are explained by index variations.
Value at Risk
17.19
17.19
The value at risk is estimated at USD 17.19. The risk is therefore 12.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002